This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) Emotional, Social, Psychological Support for Cancer (194) Innovations and Technology in Cancer Care (423)

Published on in Vol 8, No 12 (2019): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/14361, first published .
Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention

Authors of this article:

Lisa Guccione1, 2 Author Orcid Image ;   Karla Gough2 Author Orcid Image ;   Allison Drosdowsky2 Author Orcid Image ;   Krista Fisher1 Author Orcid Image ;   Timothy Price3 Author Orcid Image ;   Nick Pavlakis4 Author Orcid Image ;   Mustafa Khasraw4 Author Orcid Image ;   David Wyld5, 6 Author Orcid Image ;   David Ransom7 Author Orcid Image ;   Grace Kong8 Author Orcid Image ;   Megan Rogers9 Author Orcid Image ;   Simone Leyden10 Author Orcid Image ;   John Leyden10 Author Orcid Image ;   Michael Michael11 Author Orcid Image ;   Penelope Schofield1, 2, 12 Author Orcid Image
Article Authors Cited by (3) Tweetations (1) Metrics

Lisa Guccione   1, 2 , BCom, BBSc, GradDipPsych, PhD ;   Karla Gough   2 , BA (Hons), PhD ;   Allison Drosdowsky   2 , BA, BSc, MPH ;   Krista Fisher   1 , BPsySc, GradDipPsych ;   Timothy Price   3 , MBBS, DHlthSc (Med), FRACP ;   Nick Pavlakis   4 , BSc, MBBS, MMED (Clin Epi), PhD, FRACP ;   Mustafa Khasraw   4 , MBChB, MD, FRCP (Lon), FRACP ;   David Wyld   5, 6 , MBBS, FRACP ;   David Ransom   7 , MBBS, MD, FRACP ;   Grace Kong   8 , MBBS (Hons), FRACP, FAANMS ;   Megan Rogers   9 , BAS, GradDipCancer/PallCareNsg, MHS ;   Simone Leyden   10 , BBM ;   John Leyden   10 , MBBS, MPH, FANZCA ;   Michael Michael   11 * , MBBS (Hons), BSc (Hons), MD, FRACP ;   Penelope Schofield   1, 2, 12 * , BSc (Hons), PhD

1 Department of Cancer Experiences Research, Peter MacCallum Cancer Center, Melbourne, Australia

2 Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia

3 Haematology and Oncology, The Queen Elizabeth Hospital, South Australia, Australia

4 Department of Medical Oncology, Royal North Shore Hospital, New South Wales, Australia

5 Department of Medical Oncology, Royal Brisbane and Women's Hospital, Queensland, Australia

6 Faculty of Medicine, University of Queensland, Brisbane, Australia

7 Medical Oncology, Fiona Stanley Hospital, Western Australia, Australia

8 Department of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia

9 Upper Gastrointestinal Cancer Service, Peter MacCallum Cancer Centre, Melbourne, Australia

10 Unicorn Foundation, Victoria, Australia

11 Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia

12 Department of Psychology and Iverson Health Innovation Research Institute, Swinburne University, Melbourne, Australia

*these authors contributed equally

Corresponding Author:

  • Lisa Guccione, BCom, BBSc, GradDipPsych, PhD
  • Department of Cancer Experiences Research
  • Peter MacCallum Cancer Center
  • 305 Grattan Street
  • Melbourne, 3000
  • Australia
  • Phone: 61 38559 5908
  • Fax: 61 38559 5909
  • Email: Lisa.Guccione@petermac.org